Taysha Gene Therapies Inc (TSHA) — Cash Flow Reinvestment Rate
Taysha Gene Therapies Inc (TSHA) has a Cash Flow Reinvestment Rate of 0.33x as of December 2022, reinvesting $4.68 Million (capex $2.31 Million plus investments $-2.37 Million) from operating cash flow of $14.28 Million. See TSHA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Taysha Gene Therapies Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Taysha Gene Therapies Inc across 1 annual periods. For the full cash flow conversion analysis, see TSHA cash flow conversion.
Annual Cash Flow Reinvestment Rate for Taysha Gene Therapies Inc (2019–2019)
Year-by-year capital reinvestment analysis for Taysha Gene Therapies Inc. See Taysha Gene Therapies Inc (TSHA) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.61x | $82.00K | $135.00K | $82.00K | — |